Fludarabine, Cyclophosphamide, Mitoxantrone plus Rituximab (FCM-R) in Frontline CLL < 70 Years

Randomized trials demonstrated the superiority of chemoimmunotherapy over chemotherapy in the frontline treatment of CLL. Based on favorable experience with the addition of mitoxantrone (M) to fludarabine (F) plus cyclophosphamide (C), we designed a pilot study testing the combination of FCM plus ri...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Leuk Res
Main Authors: Faderl, Stefan, Wierda, William, O'Brien, Susan, Ferrajoli, Alessandra, Lerner, Susan, Keating, Michael J.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4845644/
https://ncbi.nlm.nih.gov/pubmed/19646755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2009.07.008
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki